Latest featured videos from Fairfield-Echo.com
Clinical Trials Update: June 30, 2008

Clinical Trials Update: June 30, 2008

Related News from HealthDay
Clinical Trials Update: Aug. 29, 2008
Clinical Trials Update: Aug. 28, 2008
Clinical Trials Update: Aug. 27, 2008
Clinical Trials Update: Aug. 26, 2008
Clinical Trials Update: Aug. 25, 2008
Clinical Trials Update: Aug. 22, 2008
Health News Archives
   

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Crohn's Disease

This study requires 10 visits over three months, with two additional visits over two years. You may be eligible if you are aged 18 to 70, have been diagnosed with moderate-to-severe Crohn's disease that is currently active, and have taken or cannot tolerate steroids such as prednisone, immunosuppressive drugs such as azathioprine, or biologics such as infliximab.

The research site is in Clearwater, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/cat51.html.

-----

Diabetes and Hypertension

If you have type 2 diabetes and are taking an oral medication, you may qualify for this trial of an investigational medication. Participants receive all study related care and study medication at no cost, and may be compensated up to $350 for time and travel.

The research site is in Las Vegas, Nev.

More information

Please see http://www.centerwatch.com/patient/studies/cat727.html .

-----

Insomnia

This study is for people aged 65 or older who have difficulty falling asleep, staying asleep, or getting a full night's sleep. Participants will receive study related care and investigational medication at no cost, and compensation is available for time and travel.

The research site is in San Antonio, Texas.

More information

Please see http://www.centerwatch.com/patient/studies/cat189.html.

-----

Copyright 2008 CenterWatch. All rights reserved.

 

Copyright © 2008 ScoutNews, LLC. All rights reserved.


Fairfield-Echo.com:

Copyright 2008 Fairfield-Echo. All rights reserved.

By using Fairfield-Echo.com, you accept the terms of our visitor agreement and privacy policy. You may wish to note our other business policies.

This website is ACAP-enabled